Cargando…
Restricted Prevalence Rates of COVID-19’s Infectivity, Hospitalization, Recovery, Mortality in the USA and Their Implications
This article constructs and demonstrates an alternate probabilistic approach (using incidence rate restricted model), compared with the deterministic mathematical models such as SIR, to capture the impact of healthcare efforts on the prevalence rate of the COVID-19’s infectivity, hospitalization, re...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546524/ https://www.ncbi.nlm.nih.gov/pubmed/33073166 http://dx.doi.org/10.1007/s41666-020-00078-0 |
_version_ | 1783592246302474240 |
---|---|
author | Shanmugam, Ramalingam |
author_facet | Shanmugam, Ramalingam |
author_sort | Shanmugam, Ramalingam |
collection | PubMed |
description | This article constructs and demonstrates an alternate probabilistic approach (using incidence rate restricted model), compared with the deterministic mathematical models such as SIR, to capture the impact of healthcare efforts on the prevalence rate of the COVID-19’s infectivity, hospitalization, recovery, and mortality in the eastern, central, mountain, and pacific time zone states in the USA. We add additional new properties for the incidence rate restricted Poisson probability distribution. With new properties, our method becomes feasible to comprehend not only the patterns of the prevalence rate of the COVID-19’s infectivity, hospitalization, recovery, and mortality but also to quantitatively assess the effectiveness of social distancing, healthcare management’s efforts to hospitalize the patients, the patient’s immunity to recover, and lastly the unfortunate mortality itself. To make regional comparisons (as the people’s movement is far more frequent within than outside the regional zone on daily basis), we group the COVID-19 data in terms of eastern, central, mountain, and pacific zone states. Several non-intuitive findings in the data results are noticed. They include the existence of imbalance, different vulnerability, and risk reduction in these four regions. For example, the impact of healthcare efforts is high in the recovery category in the pacific states. The impact is less in the hospitalization category in the mountain states. The least impact is seen in the infectivity category in the eastern zone states. A few thoughts on future research work are cited. It requires collecting rich data on COVID-19 and extracting valuable information for better public health policies. |
format | Online Article Text |
id | pubmed-7546524 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-75465242020-10-14 Restricted Prevalence Rates of COVID-19’s Infectivity, Hospitalization, Recovery, Mortality in the USA and Their Implications Shanmugam, Ramalingam J Healthc Inform Res Research Article This article constructs and demonstrates an alternate probabilistic approach (using incidence rate restricted model), compared with the deterministic mathematical models such as SIR, to capture the impact of healthcare efforts on the prevalence rate of the COVID-19’s infectivity, hospitalization, recovery, and mortality in the eastern, central, mountain, and pacific time zone states in the USA. We add additional new properties for the incidence rate restricted Poisson probability distribution. With new properties, our method becomes feasible to comprehend not only the patterns of the prevalence rate of the COVID-19’s infectivity, hospitalization, recovery, and mortality but also to quantitatively assess the effectiveness of social distancing, healthcare management’s efforts to hospitalize the patients, the patient’s immunity to recover, and lastly the unfortunate mortality itself. To make regional comparisons (as the people’s movement is far more frequent within than outside the regional zone on daily basis), we group the COVID-19 data in terms of eastern, central, mountain, and pacific zone states. Several non-intuitive findings in the data results are noticed. They include the existence of imbalance, different vulnerability, and risk reduction in these four regions. For example, the impact of healthcare efforts is high in the recovery category in the pacific states. The impact is less in the hospitalization category in the mountain states. The least impact is seen in the infectivity category in the eastern zone states. A few thoughts on future research work are cited. It requires collecting rich data on COVID-19 and extracting valuable information for better public health policies. Springer International Publishing 2020-10-09 /pmc/articles/PMC7546524/ /pubmed/33073166 http://dx.doi.org/10.1007/s41666-020-00078-0 Text en © Springer Nature Switzerland AG 2020 |
spellingShingle | Research Article Shanmugam, Ramalingam Restricted Prevalence Rates of COVID-19’s Infectivity, Hospitalization, Recovery, Mortality in the USA and Their Implications |
title | Restricted Prevalence Rates of COVID-19’s Infectivity, Hospitalization, Recovery, Mortality in the USA and Their Implications |
title_full | Restricted Prevalence Rates of COVID-19’s Infectivity, Hospitalization, Recovery, Mortality in the USA and Their Implications |
title_fullStr | Restricted Prevalence Rates of COVID-19’s Infectivity, Hospitalization, Recovery, Mortality in the USA and Their Implications |
title_full_unstemmed | Restricted Prevalence Rates of COVID-19’s Infectivity, Hospitalization, Recovery, Mortality in the USA and Their Implications |
title_short | Restricted Prevalence Rates of COVID-19’s Infectivity, Hospitalization, Recovery, Mortality in the USA and Their Implications |
title_sort | restricted prevalence rates of covid-19’s infectivity, hospitalization, recovery, mortality in the usa and their implications |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546524/ https://www.ncbi.nlm.nih.gov/pubmed/33073166 http://dx.doi.org/10.1007/s41666-020-00078-0 |
work_keys_str_mv | AT shanmugamramalingam restrictedprevalenceratesofcovid19sinfectivityhospitalizationrecoverymortalityintheusaandtheirimplications |